Celcuity Inc. (NASDAQ:CELC)
| Market Cap | 3.21B+32.9% |
| Revenue (ttm) | 0 |
| Net Income | -226.48M-52.3% |
| EPS | -4.29-24.3% |
| Shares Out | 48.77M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,654,256 |
| Open | 70.52 |
| Previous Close | 71.25 |
| Day's Range | 64.26 - 73.50 |
| 52-Week Range | 45.03 - 151.02 |
| Beta | 0.16 |
| Analysts | Buy |
| Price Target | 159.88(+143.05%) |
| Earnings Date | Nov 11, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About CELC
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CELC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in CELC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CELC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CELC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CELC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CELC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CELC
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $124.43M |
| XBIState Street SPDR S&P Biotech ETF | $89.34M |
| IWMiShares Russell 2000 ETF | $71.56M |
| VXFVanguard Extended Market ETF | $39.38M |
| IWOiShares Russell 2000 Growth ETF | $25.67M |
| VTWOVanguard Russell 2000 ETF | $19.70M |
Estimated from each fund’s disclosed top holdings × AUM
CELC Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CELC’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score